Announcements Trials

Browse Landscape

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 519 Specimen Handling 382 Carboplatin 374 Magnetic Resonance Spectroscopy 337 Cisplatin 328 Nivolumab 309 Cyclophosphamide 296 Radiotherapy 256 Paclitaxel 256 Gemcitabine 235 Biopsy 234 Bevacizumab 213 Dexamethasone 169 durvalumab 166 Oxaliplatin 162 Rituximab 158 Capecitabine 157 Fluorouracil 148 venetoclax 147 Docetaxel 146 Etoposide 141 atezolizumab 140 Drug Therapy 140 Doxorubicin 134 Ipilimumab 130 Prednisone 120 Lenalidomide 119 Radiosurgery 118 Leucovorin 112 fludarabine 108

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × antisecretory factor × 1 year × Clear all

NCT07364786 2026-01-23

AFGBMBiop

Skane University Hospital

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡